One of the study leaders is Dr. Joseph Korn of Boston University, a member of the Scleroderma Foundation's Medical Advisory Board and a recent columnist in the Foundation's magazine. Environmental factors are suspected of playing a role, but the data must be studied before any conclusions can be made. Sometimes I feel like I'm hitting a brick wall. But now we have the attention of some important people. The Scleroderma Foundation in no way endorses any drugs or treatments reported on this website.
Information is provided as a resource to be used with discretion.
Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with one's physician to assure proper evaluation and treatment.